Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Current Trends Influenza Activity -- Nevada

Isolation of two influenza viruses from persons in Las Vegas, Nevada, during late October 1984 has been reported. They have been preliminarily identified as related to A/Philippines/2/82(H3N2). The first isolate was from a 63-year-old woman who developed fever of 39.4 C (103 F), headache, and myalgias on October 24 and was admitted to a local hospital for 6 days. The second was from a 77-year-old man with chronic obstructive pulmonary disease, who was hospitalized on October 29 following onset of fever (38.9 C (102 F)), headache, myalgias, and nausea. No influenza outbreaks have been reported in Nevada. Reported by J Clark, P Reichelderfer, PhD, J Oparnico, Sunrise Hospital, N Venger, MD, K Fazekas, MD, Las Vegas, J Constantino, O Ravenholt, MD, Clark County Health Dept, GE Reynolds, MD, State Epidemiologist, Nevada State Dept of Human Resources; WHO Collaborating Center for Influenza, Influenza Br, Div of Viral Diseases, Center for Infectious Diseases, CDC.

Editorial Note

Editorial Note: It is common for sporadic isolates of influenza to be reported at this time of year in the United States, indicating low-level spread of virus in the population. Both patients in Nevada were hospitalized, illustrating the potential benefit of administering influenza vaccine annually to those persons at greatest risk of complications from influenza infections. The Immunization Practices Advisory Committee (ACIP) has recommended that priority be given to develop special programs for administration of vaccine to two of the groups at high risk: (1) adults and children with chronic disorders of the cardiovascular or pulmonary systems severe enough to have required regular medical follow-ups or hospitalization during the preceding year; (2) residents of nursing homes and other chronic-care facilities (e.g., institutions housing patients of any age with chronic medical conditions) (1).

Influenza vaccine, although normally given in the fall, should continue to be administered to persons in the above high-priority groups, as well as to persons in other groups recommended to receive it (1), up to the time influenza epidemics are occurring. Physicians and administrators of facilities providing care for persons at high risk are also encouraged to evaluate the organization and outcome of present vaccination activities to determine whether changes could improve the delivery of vaccine to high-priority groups during the 1985-1986 season.

CDC will make available to health-care organizations and public health or voluntary agencies camera-ready copies of a revised brochure, "What You Should Know About 'Flu and 'Flu Shots," suitable for reprinting locally. Requests should be sent to the Centers for Disease Control, Influenza Branch, Division of Viral Diseases, Building 7, Room 111, Atlanta, Georgia 30333. In addition, a limited number of printed brochures is available from the above address. Requests for these should include a preaddressed, adhesive label to facilitate mailing the brochures.


  1. ACIP. Prevention and control of influenza. MMWR 1984:33:253-60, 265-6.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version ( and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #